scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Hancock RE | |
Patrzykat A | |||
P433 | issue | 1 | |
P921 | main subject | antibiotic | Q12187 |
antimicrobial peptide | Q1201508 | ||
P304 | page(s) | 79-83 | |
P577 | publication date | 2002-03-01 | |
P1433 | published in | Current drug targets. Infectious disorders | Q27719435 |
P1476 | title | Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics | |
P478 | volume | 2 |
Q51116525 | A linguistic model for the rational design of antimicrobial peptides. |
Q40403120 | APD: the Antimicrobial Peptide Database |
Q58855709 | Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1Ta |
Q33291458 | Analysis and prediction of antibacterial peptides. |
Q35890738 | Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens |
Q33528189 | AntiBP2: improved version of antibacterial peptide prediction |
Q38856502 | Antimicrobial Peptides: Insights into Membrane Permeabilization, Lipopolysaccharide Fragmentation and Application in Plant Disease Control. |
Q30855629 | Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification |
Q34411550 | Antimicrobial activity of peptides derived from olive flounder lipopolysaccharide binding protein/bactericidal permeability-increasing protein (LBP/BPI) |
Q36716349 | Antimicrobial lactoferrin peptides: the hidden players in the protective function of a multifunctional protein |
Q37847357 | Antimicrobial peptide from spider venom inhibits Chlamydia trachomatis infection at an early stage |
Q33883742 | Antimicrobial peptide therapeutics for cystic fibrosis |
Q38042296 | Antimicrobial peptides and skin: a paradigm of translational medicine |
Q29547675 | Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? |
Q38128298 | Antimicrobial peptides: versatile biological properties |
Q35554403 | Approach to resistant gram-negative bacterial pulmonary infections in patients with cystic fibrosis |
Q64080741 | Bactericidal activity of 3D-printed hydrogel dressing loaded with gallium maltolate |
Q30397773 | Biological and immunotoxicity evaluation of antimicrobial peptide-loaded coatings using a layer-by-layer process on titanium |
Q36897327 | Cathelicidins and functional analogues as antisepsis molecules. |
Q28395363 | Cationic antimicrobial peptide LL-37 is effective against both extra- and intracellular Staphylococcus aureus |
Q38547203 | Challenges and Limits Using Antimicrobial Peptides in Boar Semen Preservation |
Q34989360 | Combination of alpha-melanocyte stimulating hormone with conventional antibiotics against methicillin resistant Staphylococcus aureus |
Q40749497 | Combined antibacterial and anti-inflammatory activity of a cationic disubstituted dexamethasone-spermine conjugate. |
Q54335468 | Comparison of in vitro antibacterial activities of two cationic peptides CM15 and CM11 against five pathogenic bacteria: Pseudomonas aeruginosa, Staphylococcus aureus, Vibrio cholerae, Acinetobacter baumannii, and Escherichia coli. |
Q37007318 | Contribution of the Tyr-1 in Plantaricin149a to disrupt phospholipid model membranes |
Q36713864 | Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. |
Q33967505 | Crystallization and preliminary X-ray analysis of cecropin B from Bombyx mori |
Q36356531 | Design and Synthesis of a Novel Cationic Peptide with Potent and Broad-Spectrum Antimicrobial Activity |
Q51825155 | Design and characterization of short hybrid antimicrobial peptides from pEM-2, mastoparan-VT1, and mastoparan-B. |
Q48140051 | Design and synthesis of cationic antibacterial peptide based on Leucrocin I sequence, antibacterial peptide from crocodile (Crocodylus siamensis) white blood cell extracts |
Q54394989 | Design of antimicrobially active small amphiphilic peptide dendrimers. |
Q52773180 | Design, characterization and expression of a novel hybrid peptides melittin (1-13)-LL37 (17-30). |
Q31166292 | Effects of cationic antimicrobial peptides on liquid-preserved boar spermatozoa |
Q50100427 | Effects of the antimicrobial peptide protegrine 1 on sperm viability and bacterial load of boar seminal doses. |
Q38768190 | Engineered cationic antimicrobial peptide (eCAP) prevents Pseudomonas aeruginosa biofilm growth on airway epithelial cells |
Q38665048 | Enhanced membrane disruption and antibiotic action against pathogenic bacteria by designed histidine-rich peptides at acidic pH |
Q111346790 | Enhancing antimicrobial activity of mastoparan-B by amino acid substitutions |
Q36230756 | Expression of cecropin B in Pichia pastoris and its bioactivity in vitro |
Q27643563 | Fowlicidin-3 is an alpha-helical cationic host defense peptide with potent antibacterial and lipopolysaccharide-neutralizing activities |
Q35790485 | Gram-negative bacterial sensors for eukaryotic signal molecules |
Q39067394 | Helicobacter pylori induces increased expression of the vitamin d receptor in immune responses |
Q35010044 | Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance? |
Q37127271 | Host defense peptides in wound healing. |
Q41911096 | Imaging Bacterial Cell Death Induced by Antimicrobial Peptides in Real Time Using High Speed AFM. |
Q40230660 | In Vitro and In Vivo Efficacy of an LpxC Inhibitor, CHIR-090, Alone or Combined with Colistin against Pseudomonas aeruginosa Biofilm. |
Q47956749 | In vitro and in vivo antimicrobial activity of two alpha-helical cathelicidin peptides and of their synthetic analogs |
Q57277910 | Individual Impact of Distinct Polysialic Acid Chain Lengths on the Cytotoxicity of Histone H1, H2A, H2B, H3 and H4 |
Q40139526 | Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3). |
Q34649469 | Inhibition of plant-pathogenic bacteria by short synthetic cecropin A-melittin hybrid peptides |
Q39045028 | Investigation of the antibacterial activity of a short cationic peptide against multidrug-resistant Klebsiella pneumoniae and Salmonella typhimurium strains and its cytotoxicity on eukaryotic cells |
Q35550971 | Investigation of the antimicrobial activity and biocompatibility of magnesium alloy coated with HA and antimicrobial peptide |
Q92662337 | Isolation and Characterization of Antimicrobial Peptides with Unusual Disulfide Connectivity from the Colonial Ascidian Synoicum turgens |
Q36150828 | MRSA--what is it, and how do we deal with the problem? |
Q47719814 | Membrane-active peptide PV3 efficiently eradicates multidrug-resistant Pseudomonas aeruginosa in a mouse model of burn infection. |
Q37295564 | Modification of a novel angiogenic peptide, AG30, for the development of novel therapeutic agents |
Q33849325 | Modular analysis of hipposin, a histone-derived antimicrobial peptide consisting of membrane translocating and membrane permeabilizing fragments |
Q42651135 | Molecular cloning and characterization of cDNA of penaeidin-like antimicrobial peptide from tiger shrimp (Penaeus monodon). |
Q34343813 | Molecular dynamics simulations of three protegrin-type antimicrobial peptides: interplay between charges at the termini, β-sheet structure and amphiphilic interactions |
Q38238202 | Molecular understanding of a potential functional link between antimicrobial and amyloid peptides |
Q40049719 | Multivalent gold nanoparticle-peptide conjugates for targeting intracellular bacterial infections |
Q36162791 | Nanoscale analysis of the effects of antibiotics and CX1 on a Pseudomonas aeruginosa multidrug-resistant strain |
Q36282948 | Noneluting enzymatic antibiofilm coatings |
Q39138273 | Novel Gemini vitamin D3 analogs: large structure/function analysis and ability to induce antimicrobial peptide |
Q47869555 | Novel antimicrobial peptides with promising activity against multidrug resistant Salmonella enterica serovar Choleraesuis and its stress response mechanism |
Q35740321 | Novel histone-derived antimicrobial peptides use different antimicrobial mechanisms |
Q38702352 | Otitis Media: A Review, with a Focus on Alternative Treatments |
Q82533255 | Penetratin analogues acting as antifungal agents |
Q51071562 | Penetratin and derivatives acting as antibacterial agents. |
Q36538861 | Peptide antimicrobial agents |
Q37598400 | Peptide design for antimicrobial and immunomodulatory applications |
Q90596621 | Phylogenetic barriers to horizontal transfer of antimicrobial peptide resistance genes in the human gut microbiota |
Q92275961 | Preparation and in Vitro Evaluation of New Composite Mesh Functionalized with Cationic Antimicrobial Peptide |
Q43563818 | Proteomic analysis reveals responsive proteins of Vibrio parahaemolyticus on exposure to cationic antimicrobial peptides |
Q53064121 | Recombinant expression of antimicrobial peptides using a novel self-cleaving aggregation tag in Escherichia coli. |
Q40116758 | Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum |
Q30397259 | Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11) |
Q39265769 | Screening and Optimizing Antimicrobial Peptides by Using SPOT-Synthesis. |
Q49967815 | Small Peptides Derived from Penetratin as Antibacterial Agents |
Q34233213 | Solution structure of a novel tryptophan-rich peptide with bidirectional antimicrobial activity |
Q45234104 | Structural and functional characterization of peptides derived from the carboxy-terminal region of a defensin from the tick Ornithodoros savignyi. |
Q39878043 | Synergistic effects of the membrane actions of cecropin-melittin antimicrobial hybrid peptide BP100 |
Q92071604 | Synergy Pattern of Short Cationic Antimicrobial Peptides Against Multidrug-Resistant Pseudomonas aeruginosa |
Q41545214 | Synthetic Antimicrobial Peptides Exhibit Two Different Binding Mechanisms to the Lipopolysaccharides Isolated from Pseudomonas aeruginosa and Klebsiella pneumoniae |
Q92988294 | Systematical Analysis of the Protein Targets of Lactoferricin B and Histatin-5 Using Yeast Proteome Microarrays |
Q42131964 | The anisin1 gene encodes a defensin-like protein and supports the fitness of Aspergillus nidulans |
Q45706670 | The application of DOSY NMR and molecular dynamics simulations to explore the mechanism(s) of micelle binding of antimicrobial peptides containing unnatural amino acids |
Q37542425 | The impact of synthetic biology on drug discovery |
Q33282119 | The lipid dependence of melittin action investigated by dual-color fluorescence burst analysis |
Q38663372 | The proteome targets of intracellular targeting antimicrobial peptides |
Q36303182 | Toward full-sequence de novo protein design with flexible templates for human beta-defensin-2. |
Q40902504 | Treatment and prevention of Staphylococcus epidermidis experimental biomaterial-associated infection by bactericidal peptide 2. |
Q36000488 | Unnatural amino acid analogues of membrane-active helical peptides with anti-mycobacterial activity and improved stability |
Q43234755 | Vitamin D(3) induces expression of human cathelicidin antimicrobial peptide 18 in newborns |
Q35173769 | Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals? |
Q34708231 | pH Dependence of microbe sterilization by cationic antimicrobial peptides |
Search more.